Biotech Snap

Biotech Snap

A daily 5-min biotech briefing

Latest news

Novartis bets $750M on ProFound's next-gen heart drugs

Novartis bets $750M on ProFound's next-gen heart drugs

Joachim Eeckhout
Vor pivots to autoimmune drugs and brings in new CEO

Vor pivots to autoimmune drugs and brings in new CEO

Joachim Eeckhout
Bayer-owned BlueRock cuts staff and shift strategy

Bayer-owned BlueRock cuts staff and shift strategy

Joachim Eeckhout
Molecular glue biotech Kymera signs with Gilead and updates Sanofi deal

Molecular glue biotech Kymera signs with Gilead and updates Sanofi deal

Joachim Eeckhout
RNA heart drug spinout to launch with $40M

RNA heart drug spinout to launch with $40M

Joachim Eeckhout
Chinese biotechs are catching up with the GLP-1 craze

Chinese biotechs are catching up with the GLP-1 craze

Joachim Eeckhout
Compass's psilocybin trial is yet another blow to the psychedelic market

Compass's psilocybin trial is yet another blow to the psychedelic market

Joachim Eeckhout
Cidara's stock doubles in value following universal flu vaccine results

Cidara's stock doubles in value following universal flu vaccine results

Joachim Eeckhout
China wants to bring biotechs back to its NASDAQ-like stock market

China wants to bring biotechs back to its NASDAQ-like stock market

Joachim Eeckhout
Vertex cures ten type 1 diabetes patients using stem cells

Vertex cures ten type 1 diabetes patients using stem cells

Joachim Eeckhout